DMII
Drugs Made In America Acquisition Ii
$10.20
+$0.01 (+0.05%)Oct 26, 2026
Key metrics
The numbers that frame DMII today
- Market cap
- $649.42M
- P/E (TTM)
- 34.0
- ROIC
- 2.6%
- Div yield
- 0%
- 52wk Low
- $9.86
- 52wk High
- $10.33
Growth
Revenue and earnings trend for DMII
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about DMII
Is Drugs Made In America Acquisition Ii a good buy?
Hold. Drugs Made In America Acquisition Ii has poor quality and mixed momentum. The setup is weak overall. We think Drugs Made In America Acquisition Ii is selling at a fair price.
What is the market capitalization of DMII?
Drugs Made In America Acquisition Ii's market capitalization is $649.42M.
What is the P/E (TTM) ratio for DMII stock?
Drugs Made In America Acquisition Ii's P/E (TTM) ratio is 34, based on trailing earnings.
What is the 52-week high for DMII stock?
The 52-week high for Drugs Made In America Acquisition Ii is $10.33. The current close of $10.20 is 1.3% below that high.
What is the 52-week low for DMII stock?
The 52-week low for Drugs Made In America Acquisition Ii is $9.86. The current close of $10.20 is 3.4% above that low.
Does DMII stock pay dividends?
Drugs Made In America Acquisition Ii does not currently show a dividend per share in the company data.